viral vectors

Antigen knockdown prevented organ rejection in minipigs, even in the absence of immunosuppression.

Discover how innovative production and clarification products improve lentiviral vector generation.

Off-the-shelf and custom plasmid DNA and viral vector products help scientists take their gene therapy research to the next level.

An innovative helper plasmid improves adeno-associated virus quality and infectivity.

Digital PCR is highly sensitive and precise, making it ideal for detecting rare targets and measuring small-fold changes.

With digital PCR (dPCR), researchers accurately and precisely quantitate nucleic acid samples.

Gene therapy may be the first step toward curing a rare genetic epilepsy.

Researchers find that an increased heart rate can induce anxiety in mice, given the right context.

In both the laboratory and clinic, scientists harness viral genetic transfer capabilities to develop gene therapies that modulate cellular function.

Learn how to be successful with transfection parameters, cell culture considerations, and assessment methodology when producing viral vectors.

Researchers build better vaccines thanks to innovative technology.

Discover tips for setting up and optimizing adeno-associated virus production.

A new genetic sensor called PRISM makes use of a host cell’s DNA replication machinery to trigger fluorescence in neurons with damaged DNA.

A new tool called PRISM draws on virus-host interactions and a DNA repair pathway to help researchers visualize how cellular stress may contribute to neurodegenerative disease.

Mass photometry is an interferometric scattering-based technique offering researchers unprecedented characterization of biomolecular complexes and oligomerization in physiologically-relevant situations.

The Georgetown University biologist studies how climate change contributes to the emergence of new zoonotic threats.

Flavivirus infections alter the skin microbiome of mice to increase the production of a sweet-smelling compound that attracts the viruses’ insect vectors, a study finds.

Explore why extracellular vesicles are attractive candidates for new therapeutic approaches.

Researchers use ddPCR to monitor quality at each stage of therapy development.